Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

71.18 -0.48 (-0.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
34 35 Next >
2 Breakout Growth Stocks to Buy for the Long Haul
These growing businesses are just starting to see the beginning of their long-term potential. 
Via The Motley Fool
Can FDA Approval Bolster DexCom, Inc.?
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value). 
Via MarketBeat
Exposures Product Safety
10 Analysts Have This to Say About DexCom
Via Benzinga
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
Via AB Newswire
Topics Economy
Exposures Interest Rates
Stock Market Rally Falls On Recession Fears; Tesla Plunges On China News: Weekly Review
The stock market rally suffered significant weekly losses as recession fears mounted. Tesla stock dived on China demand concerns. 
Via Investor's Business Daily
Dexcom Flirts With Breakout After FDA Clears Next-Gen Diabetes Device
The company will launch its G7 in the U.S. "in the coming months." 
Via Investor's Business Daily
Is This Stock-Split Stock a Buy For 2023?
Don't buy this company's shares for its recent stock split. 
Via The Motley Fool
Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market
A down market doesn't mean you should hit pause on adding new stocks to your portfolio. 
Via The Motley Fool
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
From DexCom, Inc.
Via Business Wire
2 Monster Stocks to Buy Without Any Hesitation
These two top stocks are giants in their respective industries with plenty of growth runway left. 
Via The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
The market is ripe with opportunity. 
Via The Motley Fool
3 Supercharged Growth Stocks to Buy for 2023
Next year could be a very important one for all three of these fast-growing businesses. 
Via The Motley Fool
Is It Too Late to Buy DexCom Stock?
The shares have been surging after the medical device specialist released its latest earnings report. 
Via The Motley Fool
Stock Market Investing Action Plan: What Part Of November Don't You Understand?
A turnabout month left the market sitting on some nice gains. The next week's data might determine whether those gains hold. 
Via Investor's Business Daily
Dexcom Leads 5 Stocks Near Buy Points
They combine strong technicals and generally sound fundamentals. 
Via Investor's Business Daily
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Don't let the current market keep you from putting spare cash to work in great companies. 
Via The Motley Fool
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
3 No-Brainer Growth Stocks to Buy for 2023 and Beyond
No-brainer growth stocks to buy for 2023 and beyond are companies that are growing their top and bottom lines and piling up the cash. 
Via InvestorPlace
Golden Cross Appears Before DexCom Investors
If history is any guide, there may be good fortune ahead for shares of DexCom (NASDAQ:DXCM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... 
Via Benzinga
Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next
These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets. 
Via The Motley Fool
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead. 
Via The Motley Fool
2 Reasons to Buy DexCom, and 1 Reason to Sell
Do the potential benefits outweigh the risks? 
Via The Motley Fool
CapitalGainsReport Sector Spotlight: Wearable Health (DXCM, WHSI, IRTC, BTCY)
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stock-Split Stocks That Are Crushing the Bear Market of Late
These widely held stock-split stocks put the bear market in its place by respectively gaining 27% and 50% in October. 
Via The Motley Fool
2 Growth Stocks That Are Soaring: Are They Buys?
Both companies are still down over the past year, but they were on fire in October. 
Via The Motley Fool
DexCom's Return On Capital Employed Insights
According to Benzinga Pro, during Q3, DexCom (NASDAQ:DXCM) earned $101.20 million, a 98.82% increase from the preceding quarter. DexCom also posted a total of $769.60 million in sales, a 11.18%... 
Via Benzinga
Is DexCom a Good Healthcare Stock to Buy Now?
After rising about 50% in October, investors want to know if this stock still has any fuel in the tank. 
Via The Motley Fool
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
From DexCom, Inc.
Via Business Wire
7 Stocks Billionaires are Buying Now
Even as markets have plunged, billionaires have been buying beaten down names. All well aware that market pullbacks are buy opportunities. 
Via InvestorPlace
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.